{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:38:07Z","timestamp":1791329887885,"version":"4.3.1"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"4-5","license":[{"start":{"date-parts":[[2006,12,27]],"date-time":"2006-12-27T00:00:00Z","timestamp":1167177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2007,3,22]]},"DOI":"10.1007\/s11064-006-9200-1","type":"journal-article","created":{"date-parts":[[2006,12,26]],"date-time":"2006-12-26T16:37:39Z","timestamp":1167151059000},"page":"739-750","source":"Crossref","is-referenced-by-count":72,"title":["Alzheimer\u2019s Disease and Cholesterol: The Fat Connection"],"prefix":"10.1007","volume":"32","author":[{"given":"Laura","family":"Canevari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,27]]},"reference":[{"key":"9200_CR1","first-page":"513","volume":"147","author":"JP Blass","year":"1991","unstructured":"Blass JP, Gibson GE (1991) The role of oxidative abnormalities in the pathophysiology of Alzheimer\u2019s disease. Rev Neurol (Paris) 147:513\u2013525","journal-title":"Rev Neurol (Paris)"},{"key":"9200_CR2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1023\/B:NERE.0000014834.06405.af","volume":"29","author":"L Canevari","year":"2004","unstructured":"Canevari L, Abramov AY, Duchen MR (2004) Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem Res 29:637\u2013650","journal-title":"Neurochem Res"},{"key":"9200_CR3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02755589","volume":"12","author":"RJ Mark","year":"1996","unstructured":"Mark RJ, Blanc EM, Mattson MP (1996) Amyloid beta-peptide and oxidative cellular injury in Alzheimer\u2019s disease. Mol Neurobiol 12:211\u2013224","journal-title":"Mol Neurobiol"},{"key":"9200_CR4","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261:921\u2013923","journal-title":"Science"},{"key":"9200_CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","volume":"349","author":"A Hofman","year":"1997","unstructured":"Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Hurskamp HF, van Duijn CN, Van Broeckhiven C, Grobbee DE (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer\u2019s disease in the Rotterdam Study. Lancet 349:151\u2013154","journal-title":"Lancet"},{"key":"9200_CR6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","volume":"57","author":"B Wolozin","year":"2000","unstructured":"Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439\u20131443","journal-title":"Arch Neurol"},{"key":"9200_CR7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","volume":"356","author":"H Jick","year":"2000","unstructured":"Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA (2000) Statins and the risk of dementia. Lancet 356:1627\u20131631","journal-title":"Lancet"},{"key":"9200_CR8","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","volume":"438","author":"FR Maxfield","year":"2005","unstructured":"Maxfield FR, Tabas I (2005) Role of cholesterol and lipid organization in disease. Nature 438:612\u2013621","journal-title":"Nature"},{"key":"9200_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","volume":"387","author":"K Simons","year":"1997","unstructured":"Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387:569\u2013572","journal-title":"Nature"},{"key":"9200_CR10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0092-8674(92)90143-Z","volume":"68","author":"KG Rothberg","year":"1992","unstructured":"Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68:673\u2013682","journal-title":"Cell"},{"key":"9200_CR11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/153537020122601002","volume":"226","author":"F Schroeder","year":"2001","unstructured":"Schroeder F, Gallegos AM, Atshaves BP, Storey SM, McIntosh AL, Petrescu AD, Huang H, Starodub O, Chao H, Yang H, Frolov A, Kier AB (2001) Recent advances in membrane microdomains: rafts, caveolae, and intracellular cholesterol trafficking. Exp Biol Med (Maywood) 226:873\u2013890","journal-title":"Exp Biol Med (Maywood)"},{"key":"9200_CR12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","volume":"232","author":"MS Brown","year":"1986","unstructured":"Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34\u201347","journal-title":"Science"},{"key":"9200_CR13","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1172\/JCI104631","volume":"41","author":"AV Chobanian","year":"1962","unstructured":"Chobanian AV, Hollander W (1962) Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol. J Clin Invest 41:1732\u20131737","journal-title":"J Clin Invest"},{"key":"9200_CR14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0005-2760(73)90014-3","volume":"316","author":"C Serougne-Gautheron","year":"1973","unstructured":"Serougne-Gautheron C, Chevallier F (1973) Time course of biosynthetic cholesterol in the adult rat brain. Biochim Biophys Acta 316:244\u2013250","journal-title":"Biochim Biophys Acta"},{"key":"9200_CR15","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","volume":"39","author":"I Bj\u00f6rkhem","year":"1998","unstructured":"Bj\u00f6rkhem I, L\u00fctjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J (1998) Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 39:1594\u20131600","journal-title":"J Lipid Res"},{"key":"9200_CR16","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","volume":"93","author":"D L\u00fctjohann","year":"1996","unstructured":"L\u00fctjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, Diczfalusy U, Bj\u00f6rkhem I (1996) Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A 93:9799\u20139804","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9200_CR17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","volume":"45","author":"JM Dietschy","year":"2004","unstructured":"Dietschy JM, Turley SD (2004) Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375\u20131397","journal-title":"J Lipid Res"},{"key":"9200_CR18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jnr.490180208","volume":"18","author":"M Saito","year":"1987","unstructured":"Saito M, Benson EP, Saito M, Rosenberg A (1987) Metabolism of cholesterol and triacylglycerol in cultured chick neuronal cells, glial cells, and fibroblasts: accumulation of esterified cholesterol in serum-free culture. J Neurosci Res 18:319\u2013325","journal-title":"J Neurosci Res"},{"key":"9200_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0173(98)00008-3","volume":"27","author":"U Beffert","year":"1998","unstructured":"Beffert U, Danik M, Krzywkowski P, Ramassamy C, Berrada F, Poirier J (1998) The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer\u2019s disease. Brain Res Rev 27:119\u2013142","journal-title":"Brain Res Rev"},{"key":"9200_CR20","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, Holtzman DM (2004) ABCA1 is required for normal central nervous system apoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 279:40987\u201340993","journal-title":"J Biol Chem"},{"key":"9200_CR21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","volume":"294","author":"DH Mauch","year":"2001","unstructured":"Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354\u20131357","journal-title":"Science"},{"key":"9200_CR22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1471-4159.2004.02183.x","volume":"88","author":"Y Liang","year":"2004","unstructured":"Liang Y, Lin S, Beyer TP, Zhang Y, Wu X, Bales KR, DeMattos RB, May PC, Li SD, Jiang XC, Eacho PI, Cao G, Paul SM (2004) A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J Neurochem 88:623\u2013634","journal-title":"J Neurochem"},{"key":"9200_CR23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","volume":"383","author":"BA Janowski","year":"1996","unstructured":"Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383:728\u2013731","journal-title":"Nature"},{"key":"9200_CR24","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1074\/jbc.M601019200","volume":"281","author":"K Abildayeva","year":"2006","unstructured":"Abildayeva K, Jansen PJ, Hirsch-Reinshagen V, Bloks VW, Bakker AHF, Ramaekers FCS, de Vente J, Groen AK, Cheryl L, Kuipers F, Mulder M (2006) 24(S)-Hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J Biol Chem 281:12799\u201312808","journal-title":"J Biol Chem"},{"key":"9200_CR25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-291X(77)90502-2","volume":"78","author":"M Sinensky","year":"1977","unstructured":"Sinensky M (1977) Isolation of a mammalian cell mutant resistant to 25-hydroxy cholesterol. Biochemical and Biophysical Research Communications 78:863\u2013867","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9200_CR26","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/jnen\/60.8.778","volume":"60","author":"T Mori","year":"2001","unstructured":"Mori T, Paris D, Town T, Rojiani AM, Sparks DL, Delledonne A, Crawford F, Abdullah LI, Humphrey JA, Dickson DW, Mullan MJ (2001) Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice. J Neuropathol Exp Neurol 60:778\u2013785","journal-title":"J Neuropathol Exp Neurol"},{"key":"9200_CR27","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.56.12.1683","volume":"56","author":"M Kivipelto","year":"2001","unstructured":"Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A (2001) Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 56:1683\u20131689","journal-title":"Neurology"},{"key":"9200_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000070182.02537.84","volume":"61","author":"MA Pappolla","year":"2003","unstructured":"Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra GM, Manjon M, Girones X, Henry TL, Matsubara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, Refolo LM (2003) Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61:199\u2013205","journal-title":"Neurology"},{"key":"9200_CR29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","volume":"64","author":"RA Whitmer","year":"2005","unstructured":"Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64:277\u2013281","journal-title":"Neurology"},{"key":"9200_CR30","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s007020170024","volume":"108","author":"GP Eckert","year":"2001","unstructured":"Eckert GP, Wood WG, M\u00fcller WE (2001) Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranes. J Neural Transm 108:1051\u20131064","journal-title":"J Neural Transm"},{"key":"9200_CR31","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00001756-200006260-00030","volume":"11","author":"A Papassotiropoulos","year":"2000","unstructured":"Papassotiropoulos A, L\u00fctjohann D, Bagli M, Locatelli S, Jessen F, Rao ML, Maier W, Bj\u00f6rkhem I, von Bergmann K, Heun R (2000) Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer\u2019s disease. Neuroreport 11:1959\u20131962","journal-title":"Neuroreport"},{"key":"9200_CR32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.62.5.753","volume":"62","author":"DL Sparks","year":"2005","unstructured":"Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C (2005) Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol 62:753\u2013757","journal-title":"Arch Neurol"},{"key":"9200_CR33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s004010000314","volume":"101","author":"R Distl","year":"2001","unstructured":"Distl R, Meske V, Ohm TG (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol (Berl) 101:547\u2013554","journal-title":"Acta Neuropathol (Berl)"},{"key":"9200_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neulet.2006.04.034","volume":"403","author":"KM Thelen","year":"2006","unstructured":"Thelen KM, Falkai P, Bayer TA, L\u00fctjohann D (2006) Cholesterol synthesis rate in human hippocampus declines with aging. Neurosci Lett 403:15\u201319","journal-title":"Neurosci Lett"},{"key":"9200_CR35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000017234","volume":"11","author":"GP Eckert","year":"2000","unstructured":"Eckert GP, Cairns NJ, Maras A, Gattaz WF, M\u00fcller WE (2000) Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: Specific changes in Alzheimer\u2019s disease. Dementia Geriatric Cogn Disord 11:181\u2013186","journal-title":"Dementia Geriatric Cogn Disord"},{"key":"9200_CR36","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1212\/01.WNL.0000161870.78572.A5","volume":"64","author":"MM Mielke","year":"2005","unstructured":"Mielke MM, Zandi PP, Sjogren M, Gustafson D, Ostling S, Steen B, Skoog I (2005) High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 64:1689\u20131695","journal-title":"Neurology"},{"key":"9200_CR37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/01.wnl.0000178989.87072.11","volume":"65","author":"G Li","year":"2005","unstructured":"Li G, Shofer JB, Kukull WA, Peskind ER, Tsuang DW, Breitner JC, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB (2005) Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. Neurology 65:1045\u20131050","journal-title":"Neurology"},{"key":"9200_CR38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archneur.61.5.705","volume":"61","author":"C Reitz","year":"2004","unstructured":"Reitz C, Tang MX, Luchsinger J, Mayeux R (2004) Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 61:705\u2013714","journal-title":"Arch Neurol"},{"key":"9200_CR39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/MN:31:1-3:185","volume":"31","author":"WG Wood","year":"2005","unstructured":"Wood WG, Igbavboa U, Eckert GP, Johnson-Anuna LN, M\u00fcller WE (2005) Is hypercholesterolemia a risk factor for Alzheimer\u2019s disease? Mol Neurobiol 31:185\u2013192","journal-title":"Mol Neurobiol"},{"key":"9200_CR40","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v66n0720","volume":"66","author":"A Papassotiropoulos","year":"2005","unstructured":"Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, L\u00fctjohann D, Nitsch RM, Hock C (2005) A cluster of cholesterol-related genes confers susceptibility for Alzheimer\u2019s disease. J Clin Psychiatry 66:940\u2013947","journal-title":"J Clin Psychiatry"},{"key":"9200_CR41","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.mp.4001109","volume":"7","author":"H Kolsch","year":"2002","unstructured":"Kolsch H, L\u00fctjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R (2002) Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer\u2019s disease. Mol Psychiatry 7:899\u2013902","journal-title":"Mol Psychiatry"},{"key":"9200_CR42","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/humu.20012","volume":"23","author":"H Katzov","year":"2004","unstructured":"Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, Prince JA (2004) Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat 23:358\u2013367","journal-title":"Hum Mutat"},{"key":"9200_CR43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00001756-200401190-00019","volume":"15","author":"KA Chalmers","year":"2004","unstructured":"Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S (2004) APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer\u2019s disease. Neuroreport 15:95\u201398","journal-title":"Neuroreport"},{"key":"9200_CR44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neulet.2004.06.011","volume":"367","author":"M Ingelsson","year":"2004","unstructured":"Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, Rebeck GW (2004) Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer\u2019s disease. Neurosci Lett 367:228\u2013231","journal-title":"Neurosci Lett"},{"key":"9200_CR45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(01)02277-7","volume":"314","author":"N Bogdanovic","year":"2001","unstructured":"Bogdanovic N, Bretillon L, Lund EG, Diczfalusy U, Lannfelt L, Winblad B, Russell DW, Bj\u00f6rkhem I. (2001) On the turnover of brain cholesterol in patients with Alzheimer\u2019s disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neuroscience Letters 314:45\u201348","journal-title":"Neuroscience Letters"},{"key":"9200_CR46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","volume":"126","author":"DL Sparks","year":"1994","unstructured":"Sparks DL, Scheff SW, Hunsaker JC III, Liu H, Landers T, Gross DR (1994) Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126:88\u201394","journal-title":"Exp Neurol"},{"key":"9200_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2002-4101","volume":"4","author":"P Zatta","year":"2002","unstructured":"Zatta P, Zambenedetti P, Stella MP, Licastro F (2002) Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits. J Alzheimers Dis 4:1\u20139","journal-title":"J Alzheimers Dis"},{"key":"9200_CR48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","volume":"7","author":"LM Refolo","year":"2000","unstructured":"Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA (2000) Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model. Neurobiol Dis 7:321\u2013331","journal-title":"Neurobiol Dis"},{"key":"9200_CR49","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1023\/B:NERE.0000042217.90204.8d","volume":"29","author":"NB Chauhan","year":"2004","unstructured":"Chauhan NB, Siegel GJ, Feinstein DL (2004) Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain. Neurochem Res 29:1897\u20131911","journal-title":"Neurochem Res"},{"key":"9200_CR50","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","volume":"98","author":"K Fassbender","year":"2001","unstructured":"Fassbender K, Simons M, Bergmann C, Stroick M, L\u00fctjohann D, Keller P, Runz H, Kuhl S, Bertsch T, von Bergmann K, Hennerici M, Beyreuther K, Hartmann T (2001) Simvastatin strongly reduces levels of Alzheimer\u2019s disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A 98:5856\u20135861","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9200_CR51","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ana.10292","volume":"52","author":"M Simons","year":"2002","unstructured":"Simons M, Schwarzler F, L\u00fctjohann D, von Bergmann K, Beyreuther K, Dichgans J, Wormstall H, Hartmann T, Schulz JB (2002) Treatment with simvastatin in normocholesterolemic patients with Alzheimer\u2019s disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol 52:346\u2013350","journal-title":"Ann Neurol"},{"key":"9200_CR52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00221-005-2243-8","volume":"164","author":"K Hoglund","year":"2005","unstructured":"Hoglund K, Syversen S, Lewczuk P, Wallin A, Wiltfang J, Blennow K (2005) Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer\u2019s disease. Exp Brain Res 164:205\u2013214","journal-title":"Exp Brain Res"},{"key":"9200_CR53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/156720505774932296","volume":"2","author":"DL Sparks","year":"2005","unstructured":"Sparks DL, Petanceska S, Sabbagh M, Connor D, Soares H, Adler C, Lopez J, Ziolkowski C, Lochhead J, Browne P (2005) Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT). Curr Alzheimer Res 2:527\u2013539","journal-title":"Curr Alzheimer Res"},{"key":"9200_CR54","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","volume":"95","author":"M Simons","year":"1998","unstructured":"Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95:6460\u20136464","journal-title":"Proc Natl Acad Sci USA"},{"key":"9200_CR55","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1074\/jbc.M205455200","volume":"278","author":"CC Curtain","year":"2003","unstructured":"Curtain CC, Ali FE, Smith DG, Bush AI, Masters CL, Barnham KJ (2003) Metal ions, pH, and cholesterol regulate the interactions of Alzheimer\u2019s disease amyloid-beta peptide with membrane lipid. J Biol Chem 278:2977\u20132982","journal-title":"J Biol Chem"},{"key":"9200_CR56","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1006\/jmbi.2001.4881","volume":"311","author":"CM Yip","year":"2001","unstructured":"Yip CM, Elton EA, Darabie AA, Morrison MR, McLaurin J (2001) Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. J Mol Biol 311:723\u2013734","journal-title":"J Mol Biol"},{"key":"9200_CR57","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0960-9822(01)00394-3","volume":"11","author":"DR Riddell","year":"2001","unstructured":"Riddell DR, Christie G, Hussain I, Dingwall C (2001) Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol 11:1288\u20131293","journal-title":"Curr Biol"},{"key":"9200_CR58","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbrc.2006.01.156","volume":"342","author":"TY Chen","year":"2006","unstructured":"Chen TY, Liu PH, Ruan CT, Chiu L, Kung FL (2006) The intracellular domain of amyloid precursor protein interacts with flotillin-1, a lipid raft protein. Biochem Biophys Res Commun 342:266\u2013272","journal-title":"Biochem Biophys Res Commun"},{"key":"9200_CR59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/nbdi.2001.0470","volume":"9","author":"S Wahrle","year":"2002","unstructured":"Wahrle S, Das P, Nyborg AC, McLendon C, Shoji M, Kawarabayashi T, Younkin LH, Younkin SG, Golde TE (2002) Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis 9:11\u201323","journal-title":"Neurobiol Dis"},{"key":"9200_CR60","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1073\/pnas.081612998","volume":"98","author":"E Kojro","year":"2001","unstructured":"Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci U S A 98:5815\u20135820","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9200_CR61","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1083\/jcb.200404149","volume":"167","author":"J Abad-Rodriguez","year":"2004","unstructured":"Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, Dingwall C, De Strooper B, Dotti CG (2004) Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167:953\u2013960","journal-title":"J Cell Biol"},{"key":"9200_CR62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","volume":"160","author":"R Ehehalt","year":"2003","unstructured":"Ehehalt R, Keller P, Haass C, Thiele C, Simons K (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160:113\u2013123","journal-title":"J Cell Biol"},{"key":"9200_CR63","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0006-2952(02)01654-4","volume":"65","author":"C Kirsch","year":"2003","unstructured":"Kirsch C, Eckert GP, Mueller WE (2003) Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol 65:843\u2013856","journal-title":"Biochem Pharmacol"},{"key":"9200_CR64","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0197-4580(02)00155-0","volume":"24","author":"IH Park","year":"2003","unstructured":"Park IH, Hwang EM, Hong HS, Boo JH, Oh SS, Lee J, Jung MW, Bang OY, Kim SU, Mook-Jung I (2003) Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. Neurobiol Aging 24:637\u2013643","journal-title":"Neurobiol Aging"},{"key":"9200_CR65","doi-asserted-by":"crossref","first-page":"16576","DOI":"10.1074\/jbc.273.26.16576","volume":"273","author":"DS Howland","year":"1998","unstructured":"Howland DS, Trusko SP, Savage MJ, Reaume AG, Lang DM, Hirsch JD, Maeda N, Siman R, Greenberg BD, Scott RW, Flood DG (1998) Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem 273:16576\u201316582","journal-title":"J Biol Chem"},{"key":"9200_CR66","doi-asserted-by":"crossref","first-page":"36815","DOI":"10.1074\/jbc.M504484200","volume":"280","author":"L Kalvodova","year":"2005","unstructured":"Kalvodova L, Kahya N, Schwille P, Ehehalt R, Verkade P, Drechsel D, Simons K (2005) Lipids as modulators of proteolytic activity of BACE\u2014Involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J Biol Chem 280:36815\u201336823","journal-title":"J Biol Chem"},{"key":"9200_CR67","doi-asserted-by":"crossref","first-page":"48508","DOI":"10.1074\/jbc.M209085200","volume":"277","author":"H Fukumoto","year":"2002","unstructured":"Fukumoto H, Deng A, Irizarry MC, Fitzgerald ML, Rebeck GW (2002) Induction of the cholesterol transporter ABCA1 in central nervous system cells by Liver X receptor agonists increases secreted Abeta levels. J Biol Chem 277:48508\u201348513","journal-title":"J Biol Chem"},{"key":"9200_CR68","doi-asserted-by":"crossref","first-page":"34674","DOI":"10.1074\/jbc.M402324200","volume":"279","author":"J Brown III","year":"2004","unstructured":"Brown J III, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B (2004) Differential expression of cholesterol hydroxylases in Alzheimer\u2019s disease. J Biol Chem 279:34674\u201334681","journal-title":"J Biol Chem"},{"key":"9200_CR69","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ncb1001-905","volume":"3","author":"L Puglielli","year":"2001","unstructured":"Puglielli L, Konopka G, Pack-Chung E, Ingano LA, Berezovska O, Hyman BT, Chang TY, Tanzi RE, Kovacs DM (2001) Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol 3:905\u2013912","journal-title":"Nat Cell Biol"},{"key":"9200_CR70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuron.2004.08.043","volume":"44","author":"B Hutter-Paier","year":"2004","unstructured":"Hutter-Paier B, Huttunen HJ, Puglielli L, Eckman CB, Kim DY, Hofmeister A, Moir RD, Domnitz SB, Frosch MP, Windisch M, Kovacs DM (2004) The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer\u2019s disease. Neuron 44:227\u2013238","journal-title":"Neuron"},{"key":"9200_CR71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.62.2.217","volume":"62","author":"PP Zandi","year":"2005","unstructured":"Zandi PP, Sparks DL, Khachaturian AS, Tschanz J, Norton M, Steinberg M, Welsh-Bohmer KA, Breitner JC (2005) Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry 62:217\u2013224","journal-title":"Arch Gen Psychiatry"},{"key":"9200_CR72","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00041433-200412000-00007","volume":"15","author":"B Wolozin","year":"2004","unstructured":"Wolozin B (2004) Cholesterol, statins and dementia. Curr Opin Lipidol 15:667\u2013672","journal-title":"Curr Opin Lipidol"},{"key":"9200_CR73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archneur.59.2.213","volume":"59","author":"S Locatelli","year":"2002","unstructured":"Locatelli S, L\u00fctjohann D, Schmidt HH, Otto C, Beisiegel U, von Bergmann K (2002) Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Arch Neurol 59:213\u2013216","journal-title":"Arch Neurol"},{"key":"9200_CR74","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archneur.60.4.510","volume":"60","author":"GL Vega","year":"2003","unstructured":"Vega GL, Weiner MF, Lipton AM, von Bergmann K, L\u00fctjohann D, Moore C, Svetlik D (2003) Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurol 60:510\u2013515","journal-title":"Arch Neurol"},{"key":"9200_CR75","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002826-199106000-00010","volume":"14","author":"RE Botti","year":"1991","unstructured":"Botti RE, Triscari J, Pan HY, Zayat J (1991) Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects. Clin Neuropharmacol 14:256\u2013261","journal-title":"Clin Neuropharmacol"},{"key":"9200_CR76","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1194\/jlr.M500024-JLR200","volume":"46","author":"M Heverin","year":"2005","unstructured":"Heverin M, Meaney S, L\u00fctjohann D, Diczfalusy U, Wahren J, Bj\u00f6rkhem I (2005) Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J Lipid Res 46:1047\u20131052","journal-title":"J Lipid Res"},{"key":"9200_CR77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jnr.10585","volume":"72","author":"M Michikawa","year":"2003","unstructured":"Michikawa M (2003) Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer\u2019s disease? J Neurosci Res 72:141\u2013146","journal-title":"J Neurosci Res"},{"key":"9200_CR78","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/WNL.57.8.1447","volume":"57","author":"LJ Launer","year":"2001","unstructured":"Launer LJ, White LR, Petrovitch H, Ross GW, Curb JD (2001) Cholesterol and neuropathologic markers of AD: a population-based autopsy study. Neurology 57:1447\u20131452","journal-title":"Neurology"},{"key":"9200_CR79","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1385\/NMM:8:3:319","volume":"8","author":"MP Burns","year":"2006","unstructured":"Burns MP, Igbavboa U, Wang LL, Wood WG, Duff K (2006) Cholesterol distribution, not total levels, correlate with altered amyloid precursor, protein processing in statin-treated mice. Neuromol Med 8:319\u2013328","journal-title":"Neuromol Med"},{"key":"9200_CR80","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","volume":"78","author":"H Paiva","year":"2005","unstructured":"Paiva H, Thelen KM, Van Coster R, Smet J, De Paepe B, Mattila KM, Laakso J, Lehtimaki T, von Bergmann K, L\u00fctjohann D, Laaksonen R (2005) High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharmacol Ther 78:60\u201368","journal-title":"Clin Pharmacol Ther"},{"key":"9200_CR81","doi-asserted-by":"crossref","first-page":"34202","DOI":"10.1074\/jbc.M505268200","volume":"280","author":"A Cordle","year":"2005","unstructured":"Cordle A, Koenigsknecht-Talboo J, Wilkinson B, Limpert A, Landreth G (2005) Mechanisms of statin-mediated inhibition of small G-protein function. J Biol Chem 280:34202\u201334209","journal-title":"J Biol Chem"},{"key":"9200_CR82","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/01.STR.0000143319.73503.38","volume":"35","author":"M Endres","year":"2004","unstructured":"Endres M, Laufs U (2004) Effects of statins on endothelium and signaling mechanisms. Stroke 35:2708\u20132711","journal-title":"Stroke"},{"key":"9200_CR83","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/07853890310001294","volume":"35","author":"H Nakagami","year":"2003","unstructured":"Nakagami H, Jensen KS, Liao JK (2003) A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms. Ann Med 35:398\u2013403","journal-title":"Ann Med"},{"key":"9200_CR84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/glia.20269","volume":"53","author":"HF Kuipers","year":"2006","unstructured":"Kuipers HF, Rappert AA, Mommaas AM, van Haastert ES, van der Vack P, Boddeke HW, Biber KP, van den Elsen PJ (2006) Simvastatin affects cell motility and actin cytoskeleton distribution of microglia. Glia 53:115\u2013123","journal-title":"Glia"},{"key":"9200_CR85","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1440-1681.2004.04010.x","volume":"31","author":"K Tanaka","year":"2004","unstructured":"Tanaka K, Honda M, Takabatake T (2004) Anti-apoptotic effect of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation. Clin Exp Pharmacol Physiol 31:360\u2013364","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9200_CR86","doi-asserted-by":"crossref","first-page":"18755","DOI":"10.1074\/jbc.M413895200","volume":"280","author":"SL Cole","year":"2005","unstructured":"Cole SL, Grudzien A, Manhart IO, Kelly BL, Oakley H, Vassar R (2005) Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism. J Biol Chem 280:18755\u201318770","journal-title":"J Biol Chem"},{"key":"9200_CR87","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0404.2006.00687.x","volume":"185","author":"B Wolozin","year":"2006","unstructured":"Wolozin B, Manger J, Bryant R, Cordy J, Green RC, McKee A (2006) Re-assessing the relationship between cholesterol, statins and Alzheimer\u2019s disease. Acta Neurol Scand Suppl 185:63\u201370","journal-title":"Acta Neurol Scand Suppl"},{"key":"9200_CR88","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","volume":"8","author":"LM Refolo","year":"2001","unstructured":"Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS, Duff KE (2001) A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Dis 8:890\u2013899","journal-title":"Neurobiol Dis"},{"key":"9200_CR89","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/jpet.104.075028","volume":"312","author":"LN Johnson-Anuna","year":"2005","unstructured":"Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, Fechner T, Schubert-Zsilavecz M, Karas M, M\u00fcller WE, Wood WG (2005) Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Therapeut 312:786\u2013793","journal-title":"J Pharmacol Exp Therapeut"},{"key":"9200_CR90","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0002-9440(10)63163-X","volume":"164","author":"RA Nixon","year":"2004","unstructured":"Nixon RA (2004) Niemann-Pick type C disease and Alzheimer\u2019s disease - The APP-endosome connection fattens up. Am J Pathol 164:757\u2013761","journal-title":"Am J Pathol"},{"key":"9200_CR91","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1023\/A:1023294820218","volume":"28","author":"M Burns","year":"2003","unstructured":"Burns M, Duff K (2003) Use of in vivo models to study the role of cholesterol in the etiology of Alzheimer\u2019s disease. Neurochem Res 28:979\u2013986","journal-title":"Neurochem Res"},{"key":"9200_CR92","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1074\/jbc.M009598200","volume":"276","author":"T Yamazaki","year":"2001","unstructured":"Yamazaki T, Chang TY, Haass C, Ihara Y (2001) Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells. J Biol Chem 276:4454\u20134460","journal-title":"J Biol Chem"},{"key":"9200_CR93","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1021\/bi010417x","volume":"40","author":"JJ Kremer","year":"2001","unstructured":"Kremer JJ, Sklansky DJ, Murphy RM (2001) Profile of changes in lipid bilayer structure caused by beta-amyloid peptide. Biochemistry 40:8563\u20138571","journal-title":"Biochemistry"},{"key":"9200_CR94","doi-asserted-by":"crossref","first-page":"15110","DOI":"10.1074\/jbc.274.21.15110","volume":"274","author":"T Mizuno","year":"1999","unstructured":"Mizuno T, Nakata M, Naiki H, Michikawa M, Wang R, Haass C, Yanagisawa K (1999) Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture. J Biol Chem 274:15110\u201315114","journal-title":"J Biol Chem"},{"key":"9200_CR95","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1096\/fj.02-0829com","volume":"16","author":"N Arispe","year":"2002","unstructured":"Arispe N, Doh M (2002) Plasma membrane cholesterol controls the cytotoxicity of Alzheimer\u2019s disease A beta P (1\u201340) and (1\u201342) peptides. Faseb J 16:1526\u20131536","journal-title":"Faseb J"},{"key":"9200_CR96","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1006\/bbrc.1994.1576","volume":"200","author":"H Hartmann","year":"1994","unstructured":"Hartmann H, Eckert A, M\u00fcller WE (1994) Apolipoprotein-E and cholesterol affect neuronal calcium signaling\u2014the possible relationship to beta-amyloid neurotoxicity. Biochem Biophys Res Commun 200:1185\u20131192","journal-title":"Biochem Biophys Res Commun"},{"key":"9200_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1007168910582","volume":"21","author":"M Kawahara","year":"2001","unstructured":"Kawahara M, Kuroda Y (2001) Intracellular calcium changes in neuronal cells induced by Alzheimer\u2019s beta-amyloid protein are blocked by estradiol and cholesterol. Cell Mol Neurobiol 21:1\u201313","journal-title":"Cell Mol Neurobiol"},{"key":"9200_CR98","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1097\/00001756-199611040-00017","volume":"7","author":"Y Zhou","year":"1996","unstructured":"Zhou Y, Richardson JS (1996) Cholesterol protects PC12 cells from beta-amyloid induced calcium disordering and cytotoxicity. Neuroreport 7:2487\u20132490","journal-title":"Neuroreport"},{"key":"9200_CR99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1471-4159.2003.01552.x","volume":"84","author":"S Subasinghe","year":"2003","unstructured":"Subasinghe S, Unabia S, Barrow CJ, Mok SS, Aguilar MI, Small DH (2003) Cholesterol is necessary both for the toxic effect of Abeta peptides on vascular smooth muscle cells and for Abeta binding to vascular smooth muscle cell membranes. J Neurochem 84:471\u2013479","journal-title":"J Neurochem"},{"key":"9200_CR100","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/S0006-3495(04)74281-2","volume":"86","author":"S Micelli","year":"2004","unstructured":"Micelli S, Meleleo D, Picciarelli V, Gallucci E (2004) Effect of sterols on beta-amyloid peptide (AbetaP 1\u201340) channel formation and their properties in planar lipid membranes. Biophys J 86:2231\u20132237","journal-title":"Biophys J"},{"key":"9200_CR101","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/bi0501030","volume":"44","author":"J Bieschke","year":"2005","unstructured":"Bieschke J, Zhang Q, Powers ET, Lerner RA, Kelly JW (2005) Oxidative metabolites accelerate Alzheimer\u2019s amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. Biochemistry 44:4977\u20134983","journal-title":"Biochemistry"},{"key":"9200_CR102","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.nbd.2006.04.015","volume":"23","author":"A Schneider","year":"2006","unstructured":"Schneider A, Schulz-Schaeffer W, Hartmann T, Schulz JB, Simons M (2006) Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons. Neurobiol Dis 23:573\u2013577","journal-title":"Neurobiol Dis"},{"key":"9200_CR103","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1096\/fj.03-0372fje","volume":"18","author":"I Sponne","year":"2004","unstructured":"Sponne I, Fifre A, Koziel V, Oster T, Olivier JL, Pillot T (2004) Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide. FASEB J 18:836\u2013838","journal-title":"FASEB J"},{"issue":"Suppl 2","key":"9200_CR104","first-page":"S136","volume":"36","author":"GP Eckert","year":"2003","unstructured":"Eckert GP, Kirsch C, Leutz S, Wood WG, M\u00fcller WE (2003) Cholesterol modulates amyloid beta-peptide\u2019s membrane interactions. Pharmacopsychiatry 36(Suppl 2):S136\u2013S143","journal-title":"Pharmacopsychiatry"},{"key":"9200_CR105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0005-2736(03)00025-7","volume":"1610","author":"W Gibson-Wood","year":"2003","unstructured":"Gibson-Wood W, Eckert GP, Igbavboa U, M\u00fcller WE (2003) Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer\u2019s disease. Biochim Biophys Acta 1610:281\u2013290","journal-title":"Biochim Biophys Acta"},{"key":"9200_CR106","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 101:2070\u20132075","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9200_CR107","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.nbd.2006.02.010","volume":"23","author":"C Malaplate-Armand","year":"2006","unstructured":"Malaplate-Armand C, Florent-Bechard S, Youssef I, Koziel V, Sponne I, Kriem B, Leininger-Muller B, Olivier JL, Oster T, Pillot T (2006) Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA(2)-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis 23:178\u2013189","journal-title":"Neurobiol Dis"},{"key":"9200_CR108","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ncb1313","volume":"7","author":"MO Grimm","year":"2005","unstructured":"Grimm MO, Grimm HS, Patzold AJ, Zinser EG, Halonen R, Duering M, Tschape JA, De Strooper B, Muller U, Shen J, Hartmann T (2005) Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol 7:1118\u20131123","journal-title":"Nat Cell Biol"},{"key":"9200_CR109","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0404.2006.00682.x","volume":"114","author":"MOW Grimm","year":"2006","unstructured":"Grimm MOW, Tschape JA, Grimm HS, Zinser EG, Hartmann T (2006) Altered membrane fluidity and lipid raft composition in presenilin-deficient cells. Acta Neurologica Scandinavica 114:27\u201332","journal-title":"Acta Neurologica Scandinavica"},{"key":"9200_CR110","first-page":"574","volume":"58","author":"MX Tang","year":"1996","unstructured":"Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P, Stern Y, Tycko B, Mayeux R (1996) Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 58:574\u2013584","journal-title":"Am J Hum Genet"},{"key":"9200_CR111","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1192\/bjp.180.5.405","volume":"180","author":"N Schupf","year":"2002","unstructured":"Schupf N, Sergievsky GH (2002) Genetic and host factors for dementia in Down\u2019s syndrome. Br J Psychiatry 180:405\u2013410","journal-title":"Br J Psychiatry"},{"key":"9200_CR112","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nm0295-135","volume":"1","author":"JA Nicoll","year":"1995","unstructured":"Nicoll JA, Roberts GW, Graham DI (1995) Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med 1:135\u2013137","journal-title":"Nat Med"},{"key":"9200_CR113","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/01.WCB.0000033200.58646.B3","volume":"22","author":"Y Liu","year":"2002","unstructured":"Liu Y, Laakso MP, Karonen JO, Vanninen RL, Nuutinen J, Soimakallio S, Aronen HJ (2002) Apolipoprotein E polymorphism and acute ischemic stroke: a diffusion- and perfusion-weighted magnetic resonance imaging study. J Cereb Blood Flow Metab 22:1336\u20131342","journal-title":"J Cereb Blood Flow Metab"},{"key":"9200_CR114","first-page":"4309","volume":"12","author":"K Horsburgh","year":"2000","unstructured":"Horsburgh K, McCulloch J, Nilsen M, Roses AD, Nicoll JA (2000) Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia. Eur J Neurosci 12:4309\u20134317","journal-title":"Eur J Neurosci"},{"key":"9200_CR115","first-page":"268","volume":"37","author":"CF Sing","year":"1985","unstructured":"Sing CF, Davignon J (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37:268\u2013285","journal-title":"Am J Hum Genet"},{"key":"9200_CR116","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-C","volume":"69","author":"Z Nagy","year":"1995","unstructured":"Nagy Z, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD (1995) Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer\u2019s disease. Neuroscience 69:757\u2013761","journal-title":"Neuroscience"},{"key":"9200_CR117","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archneur.55.7.1001","volume":"55","author":"MJ McNamara","year":"1998","unstructured":"McNamara MJ, Gomez-Isla T, Hyman BT (1998) Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease. Arch Neurol 55:1001\u20131004","journal-title":"Arch Neurol"},{"key":"9200_CR118","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z","volume":"48","author":"GE Gibson","year":"2000","unstructured":"Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, Mohs RC, Sheu RK, Blass JP (2000) Mitochondrial damage in Alzheimer\u2019s disease varies with apolipoprotein E genotype. Ann Neurol 48:297\u2013303","journal-title":"Ann Neurol"},{"key":"9200_CR119","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biochi.2005.10.007","volume":"88","author":"A Rapp","year":"2006","unstructured":"Rapp A, Gmeiner B, Huttinger M (2006) Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes. Biochimie 88:473\u2013483","journal-title":"Biochimie"},{"key":"9200_CR120","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","volume":"74","author":"M Michikawa","year":"2000","unstructured":"Michikawa M, Fan QW, Isobe I, Yanagisawa K (2000) Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem 74:1008\u20131016","journal-title":"J Neurochem"},{"key":"9200_CR121","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.chemphyslip.2005.06.005","volume":"137","author":"NC Stratman","year":"2005","unstructured":"Stratman NC, Castle CK, Taylor BM, Epps DE, Melchior GW, Carter DB (2005) Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide. Chem Phys Lipids 137:52\u201361","journal-title":"Chem Phys Lipids"},{"key":"9200_CR122","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1523\/JNEUROSCI.19-12-04867.1999","volume":"19","author":"M Buttini","year":"1999","unstructured":"Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW (1999) Expression of human apolipoprotein E3 or E4 in the brains of ApoE-\/- mice: isoform-specific effects on neurodegeneration. J Neurosci 19:4867\u20134880","journal-title":"J Neurosci"},{"key":"9200_CR123","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1046\/j.1471-4159.2000.0741579.x","volume":"74","author":"JN Keller","year":"2000","unstructured":"Keller JN, Lauderback CM, Butterfield DA, Kindy MS, Yu J, Markesbery WR (2000) Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice. J Neurochem 74:1579\u20131586","journal-title":"J Neurochem"},{"key":"9200_CR124","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1523\/JNEUROSCI.18-01-00195.1998","volume":"18","author":"J Jordan","year":"1998","unstructured":"Jordan J, Galindo MF, Miller RJ, Reardon CA, Getz GS, LaDu MJ (1998) Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci 18:195\u2013204","journal-title":"J Neurosci"},{"key":"9200_CR125","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","volume":"270","author":"MJ LaDu","year":"1995","unstructured":"LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT (1995) Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J Biol Chem 270:9039\u20139042","journal-title":"J Biol Chem"},{"key":"9200_CR126","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1194\/jlr.M400486-JLR200","volume":"46","author":"RM Lane","year":"2005","unstructured":"Lane RM, Farlow MR (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer\u2019s disease. J Lipid Res 46:949\u2013968","journal-title":"J Lipid Res"},{"key":"9200_CR127","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1212\/01.wnl.0000192102.41141.9e","volume":"66","author":"Y Huang","year":"2006","unstructured":"Huang Y (2006) Apolipoprotein E and Alzheimer disease. Neurology 66:S79-S85","journal-title":"Neurology"},{"key":"9200_CR128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1385\/JMN:23:3:181","volume":"23","author":"KA Crutcher","year":"2004","unstructured":"Crutcher KA (2004) Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer\u2019s disease. J Mol Neurosci 23:181\u2013188","journal-title":"J Mol Neurosci"},{"key":"9200_CR129","doi-asserted-by":"crossref","first-page":"18694","DOI":"10.1073\/pnas.0508254102","volume":"102","author":"S Chang","year":"2005","unstructured":"Chang S, ran MT, Miranda RD, Balestra ME, Mahley RW, Huang Y (2005) Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci USA 102:18694\u201318699","journal-title":"Proc Natl Acad Sci USA"},{"key":"9200_CR130","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"RW Mahley","year":"2006","unstructured":"Mahley RW, Weisgraber KH, Huang Y (2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease. Proc Natl Acad Sci USA 103:5644\u20135651","journal-title":"Proc Natl Acad Sci USA"},{"key":"9200_CR131","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/nbdi.2002.0485","volume":"10","author":"DT Walsh","year":"2002","unstructured":"Walsh DT, Montero RM, Bresciani LG, Jen AY, Leclercq PD, Saunders D, EL-Amir AN, Gbadamoshi L, Gentleman SM, Jen LS (2002) Amyloid-beta peptide is toxic to neurons in vivo via indirect mechanisms. Neurobiol Dis 10:20\u201327","journal-title":"Neurobiol Dis"},{"key":"9200_CR132","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1523\/JNEUROSCI.23-12-05088.2003","volume":"23","author":"AY Abramov","year":"2003","unstructured":"Abramov AY, Canevari L, Duchen MR (2003) Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 23:5088\u20135095","journal-title":"J Neurosci"},{"key":"9200_CR133","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1073\/pnas.0502066102","volume":"102","author":"A Quist","year":"2005","unstructured":"Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione B, Kagan B, Ghiso J, Lal R (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A 102:10427\u201310432","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9200_CR134","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1523\/JNEUROSCI.4042-03.2004","volume":"24","author":"AY Abramov","year":"2004","unstructured":"Abramov AY, Canevari L, Duchen MR (2004) Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24:565\u2013575","journal-title":"J Neurosci"},{"key":"9200_CR135","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1523\/JNEUROSCI.1632-05.2005","volume":"25","author":"AY Abramov","year":"2005","unstructured":"Abramov AY, Jacobson J, Wientjes F, Hothersall J, Canevari L, Duchen MR (2005) Expression and modulation of an NADPH oxidase in mammalian astrocytes. J Neurosci 25:9176\u20139184","journal-title":"J Neurosci"},{"key":"9200_CR136","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/jnr.10085","volume":"66","author":"J Keelan","year":"2001","unstructured":"Keelan J, Allen NJ, Antcliffe D, Pal S, Duchen MR (2001) Quantitative imaging of glutathione in hippocampal neurons and glia in culture using monochlorobimane. J Neurosci Res 66:873\u2013884","journal-title":"J Neurosci Res"},{"key":"9200_CR137","doi-asserted-by":"crossref","first-page":"15493","DOI":"10.1074\/jbc.274.22.15493","volume":"274","author":"V DellaBianca","year":"1999","unstructured":"DellaBianca V, Dusi S, Bianchini E, Dal P I, Rossi F (1999) beta-amyloid activates the O- 2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer\u2019s disease. J Biol Chem 274:15493\u201315499","journal-title":"J Biol Chem"},{"key":"9200_CR138","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/bbrc.2000.2897","volume":"273","author":"S Shimohama","year":"2000","unstructured":"Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura A, Chiba S, Perry G, Smith MA, Fujimoto S (2000) Activation of NADPH oxidase in Alzheimer\u2019s disease brains. Biochem Biophys Res Commun 273:5\u20139","journal-title":"Biochem Biophys Res Commun"},{"key":"9200_CR139","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-5793(03)00845-7","volume":"550","author":"D Shao","year":"2003","unstructured":"Shao D, Segal AW, Dekker LV (2003) Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett 550:101\u2013106","journal-title":"FEBS Lett"},{"key":"9200_CR140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.emboj.7600066","volume":"23","author":"F Vilhardt","year":"2004","unstructured":"Vilhardt F, van Deurs B (2004) The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J 23:739\u2013748","journal-title":"EMBO J"},{"key":"9200_CR141","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/07853890310001294","volume":"35","author":"H Nakagami","year":"2003","unstructured":"Nakagami H, Jensen KS, Liao JK (2003) A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms. Ann Med 35:398\u2013403","journal-title":"Ann Med"},{"key":"9200_CR142","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0021-9150(01)00563-9","volume":"160","author":"M Rosenblat","year":"2002","unstructured":"Rosenblat M, Aviram M (2002) Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. Atherosclerosis 160:69\u201380","journal-title":"Atherosclerosis"},{"key":"9200_CR143","doi-asserted-by":"crossref","first-page":"51451","DOI":"10.1074\/jbc.M404635200","volume":"279","author":"A Jana","year":"2004","unstructured":"Jana A, Pahan K (2004) Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer\u2019s disease. J Biol Chem 279:51451\u201351459","journal-title":"J Biol Chem"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-006-9200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-006-9200-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-006-9200-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T02:57:25Z","timestamp":1628305045000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-006-9200-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,27]]},"references-count":143,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2007,3,22]]}},"alternative-id":["9200"],"URL":"https:\/\/doi.org\/10.1007\/s11064-006-9200-1","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,27]]}}}